615 related articles for article (PubMed ID: 27678349)
1. Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease.
Catanzaro R; Cuffari B; Italia A; Marotta F
World J Gastroenterol; 2016 Sep; 22(34):7660-75. PubMed ID: 27678349
[TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic fatty pancreas disease.
Alempijevic T; Dragasevic S; Zec S; Popovic D; Milosavljevic T
Postgrad Med J; 2017 Apr; 93(1098):226-230. PubMed ID: 28069746
[TBL] [Abstract][Full Text] [Related]
3. Type 2 diabetes: Does pancreatic fat really matter?
Guglielmi V; Sbraccia P
Diabetes Metab Res Rev; 2018 Feb; 34(2):. PubMed ID: 28984071
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis.
Filippatos TD; Alexakis K; Mavrikaki V; Mikhailidis DP
Dig Dis Sci; 2022 Jan; 67(1):26-41. PubMed ID: 33469809
[TBL] [Abstract][Full Text] [Related]
5. Non-Alcoholic Fatty Pancreas Disease (NAFPD): A Silent Spectator or the Fifth Component of Metabolic Syndrome? A Literature Review.
Romana BS; Chela H; Dailey FE; Nassir F; Tahan V
Endocr Metab Immune Disord Drug Targets; 2018; 18(6):547-554. PubMed ID: 29595117
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic fatty pancreas disease and Nonalcoholic fatty liver disease: more than ectopic fat.
Della Corte C; Mosca A; Majo F; Lucidi V; Panera N; Giglioni E; Monti L; Stronati L; Alisi A; Nobili V
Clin Endocrinol (Oxf); 2015 Nov; 83(5):656-62. PubMed ID: 26201937
[TBL] [Abstract][Full Text] [Related]
7. Enlarged pancreas: not always a cancer.
Calculli L; Festi D; Pezzilli R
Hepatobiliary Pancreat Dis Int; 2015 Feb; 14(1):107-8. PubMed ID: 25655299
[TBL] [Abstract][Full Text] [Related]
8. The association between pancreas steatosis and metabolic syndrome: A systematic review and meta-analysis.
Bi Y; Wang JL; Li ML; Zhou J; Sun XL
Diabetes Metab Res Rev; 2019 Jul; 35(5):e3142. PubMed ID: 30767421
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic Fatty Pancreas Disease.
Shah N; Rocha JP; Bhutiani N; Endashaw O
Nutr Clin Pract; 2019 Oct; 34 Suppl 1():S49-S56. PubMed ID: 31535735
[TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic fatty pancreas disease - practices for clinicians.
Pinte L; Balaban DV; Băicuş C; Jinga M
Rom J Intern Med; 2019 Sep; 57(3):209-219. PubMed ID: 30901317
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic fatty pancreas disease: An emerging clinical challenge.
Zhang CL; Wang JJ; Li JN; Yang Y
World J Clin Cases; 2021 Aug; 9(23):6624-6638. PubMed ID: 34447810
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic Fatty Pancreas Disease: Clinical Consequences.
Dite P; Blaho M; Bojkova M; Jabandziev P; Kunovsky L
Dig Dis; 2020; 38(2):143-149. PubMed ID: 31865317
[TBL] [Abstract][Full Text] [Related]
13. [Lipid accumulation in the pancreas: clinical significance of NAFPD (non-alcoholic fatty pancreas disease)].
Jermendy G
Orv Hetil; 2022 Oct; 163(44):1735-1742. PubMed ID: 36309887
[TBL] [Abstract][Full Text] [Related]
14. A prospective evaluation of fatty pancreas by using EUS.
Sepe PS; Ohri A; Sanaka S; Berzin TM; Sekhon S; Bennett G; Mehta G; Chuttani R; Kane R; Pleskow D; Sawhney MS
Gastrointest Endosc; 2011 May; 73(5):987-93. PubMed ID: 21521567
[TBL] [Abstract][Full Text] [Related]
15. The Clinical Implications of Fatty Pancreas: A Concise Review.
Khoury T; Asombang AW; Berzin TM; Cohen J; Pleskow DK; Mizrahi M
Dig Dis Sci; 2017 Oct; 62(10):2658-2667. PubMed ID: 28791556
[TBL] [Abstract][Full Text] [Related]
16. Fatty pancreas disease: clinical impact.
Blaho M; Dítě P; Kunovský L; Martínek A
Vnitr Lek; 2018; 64(10):949-952. PubMed ID: 30590942
[TBL] [Abstract][Full Text] [Related]
17. The association of fatty pancreas with subclinical atherosclerosis in nonalcoholic fatty liver disease.
Ozturk K; Dogan T; Celikkanat S; Ozen A; Demirci H; Kurt O; Turker T; Yilmaz Y; Uygun A
Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):411-417. PubMed ID: 29309395
[TBL] [Abstract][Full Text] [Related]
18. [NON-ALCOHOLIC FATTY PANCREATIC DISEASE (NAFPD) AND THE METABOLIC SYNDROME: INITIATING FACTOR OR ADDITIONAL COMPONENT?].
Grigorieva IN; Efimova OV; Tov NL; Suvorova TS
Eksp Klin Gastroenterol; 2015; (9):86-91. PubMed ID: 26931016
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic steatosis and metabolic pancreatic disease: a new entity?
Caldart F; de Pretis N; Luchini C; Ciccocioppo R; Frulloni L
Intern Emerg Med; 2023 Nov; 18(8):2199-2208. PubMed ID: 37462859
[TBL] [Abstract][Full Text] [Related]
20. Enigmatic ectopic fat: prevalence of nonalcoholic fatty pancreas disease and its associated factors in a Chinese population.
Wang CY; Ou HY; Chen MF; Chang TC; Chang CJ
J Am Heart Assoc; 2014 Feb; 3(1):e000297. PubMed ID: 24572250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
